Drugmaker Jumps 1,900% as Korea Retail Traders Bet on Covid Cure

Published September 14, 2020

The best-performing stock in South Korea this year has ridden a gain of over 1,900% to a market value of more than $6 billion as the nation’s retail investor horde bets on a possible coronavirus treatment.